Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
Glizorem 80 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored tablets. The tablet can be divided into equal doses. |
Each Glizorem 80 mg tablet contains 80 mg gliclazide.
Excipients with known effect:
Each Glizorem 80 mg tablet contains 43 mg lactose.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Gliclazide |
Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. |
| List of Excipients |
|---|
|
Lactose |
PVC/Aluminium blisters. Pack-sizes of 20, 30 and 100 tablets.
Not all pack-sizes may be marketed.
Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
20347
Date of first authorization: 02 June 2008
Date of latest renewal: 20 December 2013
| Drug | Countries | |
|---|---|---|
| GLIZOREM | Cyprus, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
